Saturday 17 October 2026
Export PRPO’s income statement to Excel — free account
Precipio, Inc.
PRPO Healthcare Diagnostics & Research
Precipio, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $24.0 million, up 29.8% from fiscal 2024. In the quarter to June 2026, revenue grew 24.2%, EPS fell 340.0%, free cash flow grew 79.6% and total debt rose 47.7%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.
21.38
1.16
−5.15%
Follow PRPO
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
6 | 6 | 5 | 5 |
| (9.76%) | (2.72%) | (7.13%) | (8.98%) | ||
| (6.58%) | (1.89%) | (4.78%) | (6.05%) | ||
ROIC |
(10.55%) | (5.90%) | (8.97%) | (7.63%) | |
Return on Tangible Assets |
(63.14%) | (12.04%) | (32.27%) | (31.05%) | |
Average Days of Receivables |
31.33 | 30.11 | 28.09 | 30.58 | |
Free Cash Flow per Share |
0.36 | 0.22 | 0.31 | 0.44 | |
Free Cash Flow |
0.59 | 0.36 | 0.56 | 0.79 | |
Capital Expenditures |
(0.29) | (0.33) | (0.24) | (0.31) | |
| Other line items | |||||
Cash ROIC |
3.48% | 1.99% | 3.16% | 4.19% | |
Accounts Receivable Turnover |
15.31 | 17.28 | 17.43 | 14.44 | |
Accounts Payable Turnover |
13.68 | 15.26 | 12.82 | 14.23 | |
Inventory Turnover |
18.26 | 16.09 | 17.16 | 16.57 | |
Average Days of Payables |
33.02 | 30.94 | 34.22 | 23.34 | |
Days of Inventory on Hand |
22.86 | 25.58 | 21.84 | 18.63 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
6.76% | 5.03% | 6.89% | 7.71% | |
Interest Coverage |
(24.19) | (16.47) | (28.11) | (31.55) | |
Operating CF/Net income |
(0.70) | (1.89) | (0.86) | (0.91) | |
Depreciation/Fixed assets |
2.15 | 2.41 | 2.44 | 1.71 | |
Capex/Depreciation |
(0.18) | (0.19) | (0.13) | (0.17) | |
Revenue per Share |
13.92 | 14.98 | 14.49 | 15.22 | |
Operating CF per Share |
0.54 | 0.43 | 0.44 | 0.62 | |
Capex per Share |
(0.18) | (0.20) | (0.13) | (0.17) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 |
Columns are period end dates